Advertisement

Advertisement

Departments

Advertisement

Advertisement



Apr
19
Today In Oncology
Study Finds Medicaid Reimbursement for Radiation Therapy Varies Widely State-to-State
Complementary and Alternative Medicine Use in Patients With Cancer
KEYNOTE-158: Pembrolizumab in Previously Treated Advanced Cervical Cancer
Addition of Radiotherapy After Breast-Conserving Surgery Based on Level of Tumor-Infiltrating Lymphocytes
Addition of Bortezomib to R-CHOP in DLBCL Subtypes Identified With Gene-Expression Profiling
View More 
;
Advertisement
Most Read Stories
Advanced HER2-Positive Breast Cancer: All Eyes on These Novel Agents
Paclitaxel or Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Cancer
FDA Expands Pembrolizumab Indication for NSCLC in First-Line Setting
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Niraparib in Late-Line Treatment of Ovarian Cancer
View More 
Most Viewed Videos
Nicholas J. van As, MD, on Prostate Cancer: Results From the PACE-B Trial Comparing Radiotherapy Techniques
Jedd D. Wolchok, MD, PhD, on The Future of Immunotherapy: Keynote Lecture
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Margaret A. Tempero, MD, on Pancreatic Cancer: NCCN Guidelines Updates
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
View More 
© 2019 HSP News Service, L.L.C.